Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Publications
▹
Home
Publication
alpha-Lipoic acid prevents the increase in atherosclerosis induced by diabetes
in apolipoprotein E-deficient mice fed high-fat/low-cholesterol diet.
Authors
Yi X, Maeda N
Submitted By
Nobuyo Maeda on 2/23/2009
Status
Published
Journal
Diabetes
Year
2006
Date Published
8/1/2006
Volume : Pages
55(8) : 2238 - 2244
PubMed Reference
16873686
Abstract
Considerable evidence indicates that hyperglycemia increases oxidative stress
and contributes to the increased incidence of atherosclerosis and cardiovascular
complications in diabetic patients. To examine the effect of alpha-lipoic acid,
a potent natural antioxidant, on atherosclerosis in diabetic mice, 3-month-old
apolipoprotein (apo) E-deficient (apoE(-/-)) mice were made diabetic by
administering streptozotocin (STZ). At 4 weeks after starting the STZ
administration, a high-fat diet with or without alpha-lipoic acid (1.65 g/kg)
was given to the mice and to nondiabetic apoE(-/-) controls. At 20 weeks,
markers of oxidative stress were significantly lower in both the diabetic
apoE(-/-) mice and their nondiabetic apoE(-/-) controls with alpha-lipoic acid
supplement than in those without it. Remarkably, alpha-lipoic acid completely
prevented the increase in plasma total cholesterol, atherosclerotic lesions, and
the general deterioration of health caused by diabetes. These protective effects
of alpha-lipoic acid were accompanied by a reduction of plasma glucose and an
accelerated recovery of insulin-producing cells in the pancreas, suggesting that
part of its effects are attributable to protecting pancreatic beta-cells from
damage. Our results suggest that dietary alpha-lipoic acid is a promising
protective agent for reducing cardiovascular complications of diabetes.
Investigators with authorship
Name
Institution
Nobuyo Maeda
University of North Carolina
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!